科研製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2016/04/19 | 6,870 | 6,930 | 6,830 | 6,900 | +70 | +1% | 159,800 |
2016/04/18 | 6,730 | 6,850 | 6,730 | 6,830 | -150 | -2.1% | 108,100 |
2016/04/15 | 6,900 | 7,010 | 6,880 | 6,980 | -40 | -0.6% | 169,300 |
2016/04/14 | 6,990 | 7,060 | 6,940 | 7,020 | +120 | +1.7% | 287,500 |
2016/04/13 | 6,790 | 6,920 | 6,760 | 6,900 | +170 | +2.5% | 192,800 |
2016/04/12 | 6,710 | 6,810 | 6,700 | 6,730 | -90 | -1.3% | 178,200 |
2016/04/11 | 6,850 | 6,880 | 6,710 | 6,820 | -30 | -0.4% | 134,700 |
2016/04/08 | 6,670 | 6,900 | 6,620 | 6,850 | +80 | +1.2% | 196,900 |
2016/04/07 | 6,600 | 6,790 | 6,570 | 6,770 | +230 | +3.5% | 229,100 |
2016/04/06 | 6,550 | 6,550 | 6,280 | 6,540 | -30 | -0.5% | 281,700 |
2016/04/05 | 6,770 | 6,860 | 6,530 | 6,570 | -190 | -2.8% | 224,900 |
2016/04/04 | 6,610 | 6,870 | 6,600 | 6,760 | +200 | +3% | 282,700 |
2016/04/01 | 6,750 | 6,760 | 6,520 | 6,560 | -250 | -3.7% | 301,800 |
2016/03/31 | 7,010 | 7,010 | 6,810 | 6,810 | -140 | -2% | 194,100 |
2016/03/30 | 6,910 | 7,020 | 6,800 | 6,950 | +20 | +0.3% | 309,600 |
2016/03/29 | 6,940 | 6,960 | 6,850 | 6,930 | -50 | -0.7% | 163,200 |
2016/03/28 | 6,900 | 6,980 | 6,880 | 6,980 | +120 | +1.7% | 207,300 |
2016/03/25 | 6,820 | 7,000 | 6,780 | 6,860 | +80 | +1.2% | 342,000 |
2016/03/24 | 6,650 | 6,830 | 6,640 | 6,780 | +160 | +2.4% | 349,500 |
2016/03/23 | 6,530 | 6,660 | 6,510 | 6,620 | +170 | +2.6% | 402,800 |
2016/03/22 | 6,600 | 6,640 | 6,410 | 6,450 | -70 | -1.1% | 707,200 |
2016/03/18 | 6,680 | 6,690 | 6,440 | 6,520 | -200 | -3% | 683,300 |
2016/03/17 | 6,900 | 6,930 | 6,670 | 6,720 | -220 | -3.2% | 864,900 |
2016/03/16 | 7,220 | 7,270 | 6,920 | 6,940 | -640 | -8.4% | 1,266,600 |
2016/03/15 | 7,500 | 7,600 | 7,430 | 7,580 | +80 | +1.1% | 256,600 |
2016/03/14 | 7,550 | 7,600 | 7,440 | 7,500 | -50 | -0.7% | 251,700 |
2016/03/11 | 7,470 | 7,570 | 7,470 | 7,550 | -10 | -0.1% | 276,400 |
2016/03/10 | 7,340 | 7,560 | 7,340 | 7,560 | +320 | +4.4% | 243,300 |
2016/03/09 | 7,260 | 7,350 | 7,180 | 7,240 | -40 | -0.5% | 210,600 |
2016/03/08 | 7,460 | 7,530 | 7,170 | 7,280 | -180 | -2.4% | 205,600 |
2016/03/07 | 7,490 | 7,510 | 7,380 | 7,460 | -60 | -0.8% | 204,000 |
2016/03/04 | 7,530 | 7,600 | 7,470 | 7,520 | -40 | -0.5% | 187,900 |
2016/03/03 | 7,570 | 7,610 | 7,460 | 7,560 | -70 | -0.9% | 215,100 |
2016/03/02 | 7,570 | 7,690 | 7,520 | 7,630 | +210 | +2.8% | 286,500 |
2016/03/01 | 7,400 | 7,460 | 7,310 | 7,420 | -70 | -0.9% | 457,400 |
2016/02/29 | 7,640 | 7,670 | 7,460 | 7,490 | -20 | -0.3% | 338,900 |
2016/02/26 | 7,370 | 7,570 | 7,360 | 7,510 | +210 | +2.9% | 330,400 |
2016/02/25 | 7,310 | 7,330 | 7,220 | 7,300 | +20 | +0.3% | 254,900 |
2016/02/24 | 7,150 | 7,390 | 7,140 | 7,280 | +110 | +1.5% | 361,300 |
2016/02/23 | 7,270 | 7,280 | 7,110 | 7,170 | -30 | -0.4% | 344,900 |
2016/02/22 | 7,070 | 7,230 | 7,060 | 7,200 | +60 | +0.8% | 234,900 |
2016/02/19 | 7,090 | 7,180 | 7,040 | 7,140 | +10 | +0.1% | 391,200 |
2016/02/18 | 6,910 | 7,240 | 6,890 | 7,130 | +470 | +7.1% | 629,300 |
2016/02/17 | 6,810 | 6,830 | 6,560 | 6,660 | -190 | -2.8% | 452,200 |
2016/02/16 | 6,860 | 7,040 | 6,820 | 6,850 | -110 | -1.6% | 244,800 |
2016/02/15 | 6,970 | 7,010 | 6,750 | 6,960 | +540 | +8.4% | 314,600 |
2016/02/12 | 6,740 | 6,790 | 6,370 | 6,420 | -640 | -9.1% | 618,200 |
2016/02/10 | 7,550 | 7,620 | 6,960 | 7,060 | -620 | -8.1% | 614,100 |
2016/02/09 | 7,880 | 7,970 | 7,610 | 7,680 | -350 | -4.4% | 396,700 |
2016/02/08 | 7,780 | 8,090 | 7,720 | 8,030 | +210 | +2.7% | 341,300 |
2251~
2300
件表示中 / 3735件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
科研薬 | 379,000円 | -6.4% | -71.8% | 5.01% | 42.33倍 | 0.94倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
キッセイ薬 | 399,000円 | +3.6% | +6.1% | 3.01% | 13.44倍 | 0.79倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
鳥居薬 | 632,000円 | +7.1% | -35.0% | 0.00% | 52.26倍 | 1.46倍 |
|
JT傘下。皮膚疾患や腎・透析、花粉症薬などアレルゲン領域に強み。塩野義製薬がTOB実施 |
ジーエヌアイ | 311,500円 | +21.7% | +999.9% | 0.00% | 13.05倍 | 4.32倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
サンバイオ | 217,100円 | - | - | 0.00% | - | 100.56倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム